Abstract
er total sleep time, a lower sleep efficiency, a higher arousal index, and a longer REM sleep latency as compared with healthy laboratory controls. Furthermore, the patient's fragmentation index, the periodic leg movements index and the periodic leg movements-arousal index were all elevated,
CASE REPORT
P.R. is a 83-year-old woman who presented since 2002 (when she was 72) walking difficulties and abnormal sensitivity in lower limbs, especially in the evening. Other symptoms included fatigue and dysesthesias on left limbs and left hemitrunk, visual acuity reduction with blurred vision, visual field reduction on left side. In the past history, she underwent a hip joint prosthesis in 2001, had an arterial hypertension and hypercholesterolaemia since 2004, and surgery for grey cataract in left eye in 2006. The patient referred also increased anxiety and insomnia.
In 2002 she performed an electromyography examination and a polysomnographic confirmatory recording. Nocturnal sleep showed a longer sleep onset latency, a short- Table I) .
Why we describe this case
A high dose intravenous corticosteroid therapy was performed and paresthesias gradually decreased. Due to her age, a disease modifying therapy for MS was not initiated.
Although the diagnosis of MS was made in 2007, the symptoms were in place earlier, at least when she was 72, but were likely attributed to the RLS. The evidence of an optic atrophy in the left eye at the ophthalmologic assessment at the time of MS diagnosis supports this assumption. Thereby, the diagnosis of a MS was established at the patient's age of 77, but the disease probably initiated years before.
A symptomatic drug treatment was prescribed with pregabalin and zolpidem, although with a low level of patient's compliance.
Since then, the patient continues to perform periodical clinical controls and periodical MRI examinations, so far showing stabilisation of MS lesion burden.
Notwithstanding, the patient complains of progressive increase of gait difficulties and paresthesias on left side of the body.
DISCUSSION
Multiple Sclerosis with onset after 50 years of age is usually described as LOMS, i.e. Late Onset Multiple Sclerosis. Although uncommon, with a prevalence calculated between 4% and 9.6%, this form of MS is usually more aggressive than the juvenile form named YOMS, i.e. Young Onset Multiple Sclerosis. In fact, the time to secondary progression of LOMS is quite shorter and the primary progressive course is more commonly observed in elderly patients.
Main questions a doctor should ask himself in this situation
At its onset, clinical symptoms usually involve motor (90% vs. 67% of juvenile form) and cerebellar system. No differences are detected between LOMS and YOMS cases for sensory disturbances, ataxia, ocular movements alterations, cognitive symptoms, and fatigue [3, 4] . A typical LOMS MRI shows supratentorial and infratentorial lesions, but more frequently spinal cord lesions are detectable. Even though MRI has high sensitivity, specificity is limited because of concomitant presence of age-related microangiopathy in these patients, which limits a precise diagnosis.
de Seze et al. conducted a clinical study in LOMS patients evaluating sensitivity and specificity of Barkhof MRI criteria for MS [5] . Study results showed that in this group of patients Barkhof criteria are less specific. Moreover, gadolinium-enhancing lesions are not frequently detected, likely due to a predominance of a degenerative process instead of inflammation. The Authors suggest to perform a spinal fluid examination and VEPs in LOMS patients, to add specificity to MRI. In fact, oligoclonal bands are present in LOMS in the same percentage of YOMS patients.
A relevant issue emerging from clinical studies is a usually delayed diagnosis in LOMS patients. A differential diagnosis should be always investigated. [6] .
Another interesting feature of this case, yet described in the literature, is the comorbidity with Restless Legs Syndrome (RLS). RLS is defined as involuntary movement disorders of legs, with unpleasant sensitivity, starting or worsening during the sleep. Disturbances improve with movement [1] . The RLS pathophysiology is probably related to a dopaminergic system dysfunction, as current evidence suggests. In 2008, a multicenter study [7] showed a higher RLS prevalence in MS patients as compared with healthy controls. In addition, comorbid RLS seems to be more frequent in the elderly subjects, in patients with a long history of 
Key points y The onset of MS in elderly subjects is unusual and is described as LOMS (Late

